Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors.

Trial Profile

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Capecitabine (Primary) ; Indibulin (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Jul 2012 Planned End Date changed from 1 Dec 2008 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 18 Jul 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Jul 2009 Planned end date changed from 1 Dec 2008 to 1 Feb 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top